Delivery Order SPE2DB20D2014-SPE2DB25FD10C
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,838.58 to AmerisourceBergen Drug Corp for Loestrin 21 1-20 Tablet (21-count packages) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitive award, which received no set-aside designation, represents a firm fixed-price delivery order to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child award issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,121.57 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,816.41 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1.5-30 tablets (21-count package). The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $3,336.32 to AmerisourceBergen Drug Corp for Loestrin 21 1.5-30 tablets (21-tablet supply) on July 31, 2025, with ultimate completion by August 1, 2025. This is a firm fixed price, non-set-aside delivery order supporting federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,898.32 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1-20 tablets (21-count packages) on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,131.85 to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Loestrin FE 1-20 tablets in 28-count packages. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award of this pharmaceutical product. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania headquarters, with an ultimate completion date of September 15, 2025. This delivery order...
- The Defense Logistics Agency awarded a $3,400.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LOESTRIN FE 1-20 tablets (28-count packaging) on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a non-set-aside, competitively awarded contract executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,133.43 to AmerisourceBergen Drug Corp for Loestrin 21 1-20 tablets (21-count packages) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order, which carried no set-aside designation, will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under a larger Indefinite Delivery Contract vehicle. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $2,999.28 from the Defense Logistics Agency on May 15, 2025, for Loestrin 21 1-20 tablets (21-tablet supply). This is a firm fixed-price, non-set-aside competitive award with an ultimate completion date of May 16, 2025. The contract represents a routine pharmaceutical supply delivery supporting federal medical procurement needs, with performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,718.66 to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This is a firm fixed-price, non-set-aside contract with a completion date of July 18, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor, is executing this order as a child contract under its broader...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD10CDelivery Order
The Defense Logistics Agency awarded a $12,314.25 firm fixed price delivery order to AmerisourceBergen Drug Corp for Loestrin 21 1.5-30 tablets (21 count packages) on September 24, 2025, with an ultimate completion date of September 25, 2025. This non-set-aside competitive award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026 that enables the company to supply medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, and medical supplies. The company's federal contract awards demonstrate significant capability in fulfilling diverse pharmaceutical needs across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard. This specific order for Loestrin, an oral contraceptive medication, exemplifies the company's role in providing essential pharmaceutical products to support military healthcare systems through competitively awarded, firm fixed price delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 9/24/25 |